Percutaneous transhepatic cholangioscopy-guided holmium laser lithotripsy for bile duct stones in elderly patients

Nhan Hien Phan, Dang Khanh Do, Hong Canh Pham, Thai Binh Nguyen · 2026

Read Percutaneous transhepatic cholangioscopy-guided holmium laser lithotripsy for bile duct stones in elderly patients by Nhan Hien Phan, Dang Khanh Do, Hong Canh Pham, Thai Binh Nguyen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0356488.txt.

Introduction

Nhan Hien Phan and colleagues reviewed fifty patients aged eighty and over treated for bile duct stones. The treatment was a through-the-liver endoscopic laser procedure at their center in 2023 and 2024. Their 2026 retrospective study chose this route because open surgery is perilous at such ages. A scope is threaded through the liver to shatter stones with a holmium laser. The team graded clearance, complications, and hospital stay.

Every patient finished with complete or near-complete clearance. Most needed a single session, and nobody died from the procedure. About a quarter had adverse events, nearly all minor. Stones lodged both inside and outside the liver, plus active bile duct infection, predicted incomplete clearance and longer stays. The authors present the technique as a feasible lifeline for the very old.

Catalog record

CREATORNhan Hien Phan, Dang Khanh Do, Hong Canh Pham, Thai Binh Nguyen
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23165
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0356488

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Percutaneous transhepatic cholangioscopy-guided holmium laser lithotripsy for bile duct stones in elderly patients Nhan Hien Phan, Dang Khanh Do, Hong Canh Pham, Thai Binh Nguyen ABSTRACT Purpose: To evaluate the safety and efficacy of percutaneous transhepatic endoscopic holmium laser lithotripsy (PTEHL) for bile duct stones in elderly patients aged ≥80 years. Materials and methods: This retrospective study included 50 patients (mean age 86.4 ± 4.5 years) who underwent PTEHL from January 2023 to December 2024. Inclusion criteria were age ≥ 80 years, presence of intra- and/or extrahepatic bile duct stones, and indication for PTEHL. Outcomes assessed included stone clearance, adverse events, and hospitalization duration. Adverse events were categorized according to the CIRSE classification. Results: PTEHL was performed once in 48 patients, while 2 patients required two sessions. Final outcomes showed that all patients achieved complete (72%) or near-complete stone clearance (28%), with no requirement for any additional subsequent treatment. Thirteen patients (26%) experienced adverse events, mostly minor; only one moderate adverse event (biliopleural fistula) was recorded. No procedure-related mortality occurred. Multivariate analysis revealed that the presence of cholangitis and combined intra- and extrahepatic stones were significantly associated with incomplete clearance. Mean hospital stay was 14.8 ± 8.0 days and was significantly longer in patients with cholangitis (p = 0.001). Conclusion: PTEHL may represent a feasible minimally invasive treatment option for elderly patients with biliary stone. Introduction Cholelithiasis is common in the elderly, with prevalence rising from 14–23% in individuals aged 65 years and older to over 80% in those over 90 years. In this population, clinical symptoms may be vague, yet complications such as cholangitis, septic shock, and organ failure are more frequent and carry higher morbidity and mortality, especially in patients with comorbidities [ 1 , 2 ]. Age-related anatomical changes and frailty further increase perioperative risks [ 1 – 3 ]. Endoscopic Retrograde Cholangiopancreatography (ERCP) is the standard for common bile duct (CBD) stones but may be less effective in large or intrahepatic stones and poses higher complication risks in older adults [ 4 , 5 ]. Altered anatomy from previous surgery can limit ERCP access. Surgery, while effective, may not be feasible due to anesthesia risks and frailty [ 6 – 8 ]. Temporary drainage via ERCP or PTBD relieves obstruction but does not clear stones. Definitive stone clearance is essential to prevent recurrent infection and improve outcomes [ 6 , 9 ]. Holmium laser lithotripsy, well established in urology, has shown promise in biliary stone management via the percutaneous transhepatic approach, particularly in patients with existing drainage tracts [ 10 – 12 ]. Percutaneous transhepatic endoscopic holmium laser lithotripsy (PTEHL) enables minimally invasive treatment without general anesthesia, with high success rates and low complication risk [ 7 , 11 – 13 ]. This study evaluates the safety and efficacy of PTEHL in patients aged 80 years and older with biliary lithiasis. Materials and methods Patient selection This retrospective study included patients who underwent PTEHL at our institution between January 1, 2023, and December 30, 2024. Medical records were accessed on February 1, 2025. The study protocol was approved by the Institutional Review Board of Hanoi Medical University (Approval No. HMUIRB1629). The requirement for informed consent was waived due to the retrospective nature of the study. At our institution, the selection of patients for PTEHL, ERCP, or surgical management was determined through a multidisciplinary team discussion involving specialists in internal medicine, gastrointestinal endoscopy, hepatopancreatobiliary surgery and interventional radiology. The inclusion criteria for PTEHL in patients aged ≥80 years were as follows: (1) patients with cholangitis who had previously undergone biliary drainage; (2) patients with significant systemic comorbidities precluding general anesthesia; (3) patients with complex biliary stones involving both intrahepatic and extrahepatic bile ducts; and (4) patients with common bile duct stones measuring >15 mm. Exclusion criteria comprised: (1) known malignancy of the bile ducts or gallbladder; (2) other active progressive malignancy; (3) severe coagulopathy; (4) severe systemic infection; and (5) isolated intrahepatic stones associated with significant atrophy of the corresponding hepatic parenchyma ( Fig 1 ). 10.1371/journal.pone.0356488.g001 Fig 1 STROBE flow diagram of patient selection. Among 582 patients who underwent PTEHL for bile duct stones between January 2023 and December 2024, 62 patients were aged ≥80 years. Of these, 12 patients were excluded because of missing pre-PTEHL CT and/or MRI data (n = 8) or missing postoperative ultrasound and cholangiography data (n = 4) . Finally, 50 patients met the eligibility criteria and were included in the final analysis. Procedure PTEHL was performed by interventional radiologists with over 10 years of hepatobiliary intervention experience (P.N.H, P.H.C, N.T.B). Access route was selected based on MRCP and ultrasound, prioritizing the most direct path while avoiding transpleural trajectories. The right or common hepatic duct was used for isolated CBD stones, whereas a contralateral approach was preferred for intrahepatic stones. In complex cases, multiple tracts were established. Lithotripsy timing depended on cholangitis severity. In Tokyo grade II-III cholangitis cases, initial biliary drainage was performed, with lithotripsy delayed until infection control. In mild or non-cholangitis cases, single-session lithotripsy was considered after interdisciplinary risk assessment. Biliary drainage was done under local anesthesia; lithotripsy utilized local anesthesia with IV sedation and monitored anesthesia care. After infiltration with 2% Lidocaine, biliary access was achieved using an 18G needle (BD Angiocath). Contrast injection confirmed ductal anatomy and stone burden. A 0.035-inch guidewire was advanced, and an 8.5 F drainage catheter (Merit) was positioned into the CBD. Bile samples were collected for culture and sensitivity testing. For lithotripsy, tract dilation was performed using 8–16 F dilators, followed by placement of a 16–18 F Amplatz sheath (Seplou Medical). A 9.5 F rigid endoscope (Karl Storz) was introduced, and Holmium laser (80–100 W, 2 J, 20 Hz) (Accutech) was used for stone fragmentation. Fragments were retrieved with baskets and flushed via continuous irrigation. Endoscopic inspection was done from intrahepatic ducts to CBD, with biopsy of suspicious lesions. A completion cholangiogram was performed before placement of a new internal-external biliary catheter ( Fig 2 ). 10.1371/journal.pone.0356488.g002 Fig 2 An 87-year-old woman presented with a 3-day history of abdominal pain, fever, and jaundice, diagnosed as Grade III acute cholangitis per Tokyo Guidelines. (A) Coronal T2-weighted MRI revealed multiple stones in the left hepatic duct and common bile duct (arrowhead). (B) PTBD was performed for decompression and bile culture. (C) After 7 days, percutaneous transhepatic endoscopic holmium laser lithotripsy (PTEHL) was initiated; the tract was dilated to 16F and an Amplatz sheath inserted. (D) A second tract was established into the common hepatic duct. (E-F) Holmium laser fragmented large stones, which were extracted with a retrieval basket. (G) Final cholangiography showed complete stone clearance. In elderly patients, multistage lithotripsy was employed to shorten procedure time and minimize fluid-related complications. Post-procedure, patients were monitored for signs of bleeding, bile leak, or fluid collection. Ultrasound was performed routinely at 24 hours or upon symptoms. Prior to discharge, repeat cholangiography and ultrasound were used to confirm clearance. The drainage catheter remained for 2–3 weeks and was removed only after imaging confirmed no residual stones. For strictures permitting guidewire passage, options included tract dilation, balloon, incision, or large-caliber catheter placement. In high-grade strictures without wire passage, definitive treatment was deferred. Antibiotic regimens were based on bile

Read the complete text